{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif3xd2e4oo3ty6xc5i5xddq5hv6imst4wl5aiacfhvovhcinr5poy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpkiqtutlde2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidkkqjry7odoe5wllznryeaxjaf75y52kyzpvcyt72k5vntmxpob4"
    },
    "mimeType": "image/jpeg",
    "size": 274001
  },
  "path": "/news/2026-06-australia-psychedelic-therapy-oversight-limited.html",
  "publishedAt": "2026-06-30T21:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels.",
  "title": "Australia relaxes psychedelic therapy oversight despite limited safety evidence"
}